Trial Profile
A Multicenter, Randomized, Double-dummy, Double-blind Study Evaluating Two Doses of Adalimumab Versus Methotrexate (MTX) in Pediatric Subjects With Chronic Plaque Psoriasis (Ps).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 May 2019
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Abbott Laboratories; AbbVie
- 24 Apr 2019 Results published in the British Journal of Dermatology
- 25 Jul 2018 Results (n=577) evalauting the totality of safety findings from 7 clinical trials (NCT00048542, NCT00775437, NCT00690573, NCT01166282, NCT01251614, NCT00409682 and NCT00686374) published in the Journal of Pediatrics
- 18 May 2017 Results published in the Lancet.